EXPERIENCE OF TREATMENT OF HEMANGIOMAS IN CHILDREN BY BETA-BLOCKERS
DOI:
https://doi.org/10.54890/.v4i4.1238Abstract
This article describes the modern methods of treatment of vascular hyperplasia, the molecular mechanisms of action of propranolol, justifying its use in this disease, the results of the clinical effect of β-blockers in the treatment of hemangiomas in children and the possibility of optimization, the dosage regimen of the drug.
Keywords:
vascular tumors, children, treatment, β-blocker.References
1. Великовская Н.В., Репина Э.А. Лечение сосудистыхгиперплазий челюстно-лицевой области с использованиемнеселективного β-адренблокатора пропранолола.- Angioma.ru 4.Sans V., et al. Propranolol for severe infantile haemangiomas: follow up report. Pediatr 2009; 124 (3): 423-31.
2. Shah S.. Treatment of Infantile Hemangiomas With Beta-Blockers. 2013; 15- 16.
3. Hogeling M., Adams S., Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Source Pediatrics. 2011 Aug; 128(2):e 259-66.
4. Поляев Ю.А., Остников С.С., Мыльников А.А. и соавт. Новые возможности в лечении инфантильных гемангиом с помощью пропранолола // Практическая медицина. 8 (64) декабрь 2012.Т.1.
5. Сычев Д.А., Цой А.Н., Кукес В.Г., Коман И.Э. Клиническое значение фармакогенетики для педиатрии // Вестник педиатрической фармакологии и нутрициологии, 2004.- Т.1.-№1.-С. 5-12.
6. Сhang L.S., et al. Growth characteristics of infantile haemangiomas: implications for management. Pediatr 2008; 122(2).
7. Erbay A., et al. Propranolol for infantile haemangiomas: a preliminary report on efficacy and safety in very low birth weigth infants. Turk J Pediatr 2010; 52( 5) : 450 -6.
8. Greenberger S., et al. Corticosteroid suppression of VEGFA in infantile haemangioma derived stem cells. Eng J Med 2010; 362 (11): 1005-13.
9. Storch C.H., Hoeger P.N. Propranolol for infantile haemangiomas: insigts into the molecular mechanisms of action. Br J Dermatol 2010; 163 (2): 269-74.
Downloads
Published
How to Cite
Issue
Section
